Postoperative Oxaliplatin, 5-FU, and Leucovorin in Patients With Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
Oncologist 2019 Dec 18;[EPub Ahead of Print], AB Chakravarthy, F Zhao, NJ Meropol, PJ Flynn, LI Wagner, J Sloan, RB Diasio, EP Mitchell, P Catalano, BJ Giantonio, RB Catalano, DG Haller, RA Awan, MF Mulcahy, TE O'Brien, R Santala, C Cripps, JR Weis, JN Atkins, CG Leichman, NJ Petrelli, FA Sinicrope, JD Brierley, JE Tepper, PJ O'Dwyer, ER Sigurdson, SR Hamilton, D Cella, AB BensonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.